CoChat

Identification of drugs that restore primary cilium expression in cancer cells

Open access
Khan, Niamat Ali, Willemarck, Nicolas, Talebi, Ali, Marchand, Arnaud, Binda, Maria Mercedes, Dehairs, Jonas, Rueda-Rincon, Natalia, Daniels, Veerle W., Bagadi, Muralidhararao, Raj, Deepak Balaji Thimiri Govinda, Vanderhoydonc, Frank, Munck, Sebastian, Chaltin, Patrick, Swinnen, Johannes V. · 2016 · Oncotarget
Cited by 80

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

// Niamat Ali Khan 1 , Nicolas Willemarck 1 , Ali Talebi 1 , Arnaud Marchand 2 , Maria Mercedes Binda 1 , Jonas Dehairs 1 , Natalia Rueda-Rincon 1 , Veerle W. Daniels 1 , Muralidhararao Bagadi 1 , Deepak Balaji Thimiri Govinda Raj 3 , Frank Vanderhoydonc 1 , Sebastian Munck 4, 5 , Patrick Chaltin 2, 6 , Johannes V. Swinnen 1 1 KU Leuven - University of Leuven, Department of Oncology, Laboratory of Lipid Metabolism and Cancer, 3000 Leuven, Belgium 2 Cistim Leuven vzw, Bioincubator 2, 3001 Leuven, Belgium 3 European Molecular Biology Laboratory (EMBL), Grenoble Outstation and Unit of Virus Host-Cell Interactions (UVHCI), UJF-EMBL-CNRS, CS 90181, France 4 VIB Bio Imaging Core and Center for the Biology of Disease, 3000 Leuven, Belgium 5 KU Leuven - University of Leuven, Center for Human Genetics, 3000 Leuven, Belgium 6 Centre for Drug Design and Discovery (CD3) KU Leuven R & D, Bioincubator 2, 3001 Leuven, Belgium Correspondence to: Johannes V. Swinnen, e-mail: johan.swinnen@med.kuleuven.be Keywords: cilium, cancer, small molecules, therapeutics, high content analysis Received: July 12, 2015 Accepted: December 08, 2015 Published: February 04, 2016 ABSTRACT The development of cancer is often accompanied by a loss of the primary cilium, a microtubule-based cellular protrusion that functions as a cellular antenna and that puts a break on cell proliferation. Hence, restoration of the primary cilium in cancer cells may represent a novel promising approach to attenuate tumor growth. Using a high content analysis-based approach we screened a library of clinically evaluated compounds and marketed drugs for their ability to restore primary cilium expression in pancreatic ductal cancer cells. A diverse set of 118 compounds stimulating cilium expression was identified. These included glucocorticoids, fibrates and other nuclear receptor modulators, neurotransmitter regulators, ion channel modulators, tyrosine kinase inhibitors, DNA gyrase/topoisomerase inhibitors, antibacterial compounds, protein inhibitors, microtubule modulators, and COX inhibitors. Certain compounds also dramatically affected the length of the cilium. For a selection of compounds (Clofibrate, Gefitinib, Sirolimus, Imexon and Dexamethasone) their ability to restore ciliogenesis was confirmed in a panel of human cancer cell line models representing different cancer types (pancreas, lung, kidney, breast). Most compounds attenuated cell proliferation, at least in part through induction of the primary cilium, as demonstrated by cilium removal using chloral hydrate. These findings reveal that several commonly used drugs restore ciliogenesis in cancer cells, and warrant further investigation of their antineoplastic properties.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.7198

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

Metadata

Authors
Khan, N. A., Willemarck, N., Talebi, A., Marchand, A., Binda, M. M., Dehairs, J., Rueda-Rincon, N., Daniels, V. W., Bagadi, M., Raj, D. B. T. G., Vanderhoydonc, F., Munck, S., Chaltin, P., & Swinnen, J. V.
Venue
Oncotarget
Published
2016-02-04
Volume
7
Issue
9
Pages
9975-9992
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2266000132
Cited by
80
References
5
FWCI
4.16
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.